Thursday, March 31, 2011
Breakthrough Biodegradable Fluorescent Material
I believe this is an amazing breakthrough material. It has such a wide range of applications but I think the most beneficial of all is the information it can provide. This material can give us a much better understanding of what is going on within the body. Doctors will be able to track drugs and monitor their effects more easily. There is just so much that this material can do for the biomedical field.
Source: http://www.uta.edu/ucomm/researchmagazine/2010/cancer/biomedical-breakthroughs.php
"Honey-Pot" Protocells Trap Viruses
This new approach uses synthetic “protocells” to combat Henipaviruses (measles, mumps, parainfluenza etc.). Henipaviruses rely on a tagging protein to mark cells for infection. The virus then stabs into the cell and injects its code. It only has one shot to proliferate.
These protocells (coated in the tagging protein) act as a viral sink, baiting viruses into attempting to infect them, and becoming ineffectual as they inject themselves into inert globules. This method works well because the administration of the treatment can work all throughout the vasculature with minimal side effects, and relies on viruses’ own machinations to accomplish the job.
In addition, this technique is extremely unlikely to generate any super-viruses, because in order for a virus to not get trapped, it would have to evolve the ability to not inject itself into things.
I found this article interesting because viruses are difficult to inhibit and kill by nature. This idea is ingenious, in that instead of killing them, it just tricks them into wasting their shot. Little cells roaming around the body attracting viruses is perfect in terms of distribution throughout the body, and reduction of viral spread. Every cell that isn’t hijacked reduces the number of viruses in the body immensely; such a massive positive feedback suffers from every single reduction, and these protocells appear to be capable of absorbing hundreds of viruses apiece. That it relies on a viral mechanism vital to viruses’ efficacy makes it even better, as the likelihood of the treatment becoming ineffectual is almost zero; the method only selects for non-infecting viruses. For an apropos analogy, see http://xkcd.com/810/.
http://www.eurekalert.org/pub_releases/2011-03/nios-uac030211.php
Researchers at the Proteome Center Tuebingen discover a new form of the protein ubiquitin that is involved with inflammation and cell death.
I thought it would be appropriate to discuss this article because it brings up several points that we should be moderately familiar with: ubiquitin, and methods for determining intracellular levels of various compounds. We are aware of what ubiquitin is: a protein that binds to other proteins and is involved with regulating the levels of those proteins. As ubiquitin binds to proteins it “marks” it for destruction and recycling. As more and more ubiquitin binds, it forms long chains in a process called polyubiquitylation. Previously there were only two forms of polyubiquitylation known. This new, third major form, is not found in the same amounts as the other two – it is typically found in amounts 30 times lower – and is classified by its linear form . Despite the relatively small amount of it discovered, it was found to play a major role in inflammation and cell death. It does so by modifying NEMO, an important regulatory protein in the NF-kappaB signal transduction pathway, is present. The NF-kappaB signal transduction pathway is one regulatory mechanism for inflammation processes and insight and research in this area can lead to new therapies for inflammation.
Discovery of this new form was difficult because of its relatively low concentration in comparison to the other two and the difficulty in distinguishing them apart from one another. Dr. Mirita Franz-Wachtel stated that, “Due to very small intracellular amounts of this modification we had to apply the most sensitive biochemical methods and instrumentation.” In fact, the most important method they had to use was mass spectrometry, a method that can measure the masses of ionized molecules. Using these methods scientists will hopefully be able to gain a deeper understanding of the protein complement of our cells and develop new and more efficient treatments.
http://www.sciencedaily.com/releases/2011/03/110331080039.htm
The ElectroHand 200
Use of Polymeric Biomaterials in Clinical Applications
Degradable biomaterials have many potential uses, including but certainly not limited to drug release and delivery, temporary structural support as a substitute for extracellular matrices, degradable stents, ocular and orthopedic implants and etc. While degradable biomaterials have potentially unlimited uses, designing them has proven difficult due to the rates at which most polymers degrade. Most implantable polymers experience a state of rigidity and compliance up to a point, after which they become more brittle and degradation proceeds quickly, making degradation rates difficult to measure and clinical trials hard to set up. Materials must be designed which degrade at a more steady or tailored state if they are to be effective.
The portion of the article which I found most interesting involved shape-memory polymers. These special polymers can be compressed to a small size, ideal for surgical insertion, and upon coming in prolonged contact with body temperatures exceeding their switching temperature they will expand to their more bulky, application-relevant shape. The article discusses multi-functional materials that incorporate the shape-memory effect, biodegradability, and drug release, the combination of which I find extremely interesting and useful, could it be optimized and put to clinical application.
John Gruetzner
Section 502
The article is available for free download as a PDF here:
http://www.artificial-organs.com/public/IJAO/Article/Article.aspx?UidArticle=C847E581-9DBF-4933-805C-A65F9E27E1CF
On new lab chip, heart cells display a behavior-guiding ‘nanosense’
Oversized Lobar Lung Allografts Might Be an Option For Transplantion in Children
Weight-Loss Surgery May Change the Shape of the Heart
The hearts of those patients who underwent bypass surgery changed in structure and decreased in heart muscle mass in the left ventricular and right ventricular cavities. This may be due to the fact that the heart is less stressed and no longer needs to work as hard to pump blood across the body.
I found this article interesting because I did not realize that bypass surgery was able to address so many problems in an obese patient’s body, including changing the structure of the heart. By doing bypass surgery the study showed that a patient’s risk of death decreased by half during a 7-8 year period.
http://healthland.time.com/2011/02/08/gastric-bypass-surgery-may-change-your-hearts-shape/
Vertebral Balloon to Treat Spinal Compression Fractures
Bioengineers create plastic from renewable biomass
Fluorescence-Guided Neurosurgery in Oncology
In recent years, oncology research has been exceeding expectations, and reaching new limits concerning determining malignant tumors, and separating them from benign areas. One area of research that is being done is through fluorescence-guided neurosurgery. This is a case where tumors are tagged with a 5-aminolevulinic acid (5-ALA) which can aid in determining cancerous cells from non cancerous cells in places where the two may be similar in appearance and in texture. This acid (which is not currently approved in the US) causes a buildup of “porphyrins in malignant gliomas” which are more easily identified. These studies were taken in Germany, at the University of Dusseldorf, where the results showed that those patients who were treated with 5-ALA had about a 20% higher chance that the malignant cells would not return, however it is still controversial to use a maximal amount of cytoreductive therapy in most cases.
This article and situation seems most interesting to me, mainly due to the visit to Germany that I have planned this summer. While there, I will be studying the History of Medicine, where many controversial issues in the states are not deemed a problem at all in most of Europe. Hopefully, I will be able to see some instances where medicine in Europe is more loosely restricted, and real research can be done. IN this case, it seems that there are relatively little side effects that can be caused by 5-ADA, and at this point in time, any research that can be improved in oncology, needs to be done.
http://www.medscape.com/viewarticle/503554
http://engineering.dartmouth.edu/research/by-discipline/biomed.html
Vaccinating Against Allergen Caused Asthma
Eye Telescope Implant
Macular degeneration is a progressive disease where a portion of the retina, called the macula, no longer functions properly. Many patients who suffer from macular degeneration can now depend on an implantable telescope in hopes of regaining their vision. The role of the retina, specifically the macula, is to convert light waves into electrical signals to be sent to the brain. So, when your macula degenerates, only light from the peripheral vision can be seen, causing severe sight loss. The pea-sized implantable telescope developed by VisionCare Ophthalmic Technologies can magnify visual information that enters the eye by almost three-fold. The telescope takes like that enters the eye and refracts it to parts of the retina that have no been affected by the macula degeneration. Consequently, areas of the retina that are used for peripheral vision are now being used to provide sight for the eye. This implant is only used in one of the eyes because when implanted, the eye will not longer have peripheral sight. So, the eye with the implant will be used for central vision, while the eye without the implant (still with macular degeneration issues) will be used for peripheral light. eyeThis device is not for everyone, but can aid those who meet the eligibility requirements, which include having end-stage macular degeneration and have failed other medical and surgical treatments.
I took great interest in this article because over spring break I met one of my brother's classmates who has macula damage of his retina and was actually dismissed from Navy flight school because of this condition. This kind of advancement could maybe one day keep this from happening again.
http://www.biomedicalblog.com/implanted-telescope-improves-vision/40100/
New Less-Invasive Technique for Colonoscopies
The new fiber optic device is not only much thinner than current techniques, but it is also much less invasive. The device uses low-coherence enhanced backscattering spectroscopy to analyze tissue samples take just at the base of the colon. There is no longer a need to investigate the entire length of the colon. Although these cells as the base of the colon may have a normal phenotype, lesions or polyps located further into the colon will have an effect on them. Those cancerous cells will cause the cells at the base of the colon to experience molecular and other changes by a biological phenomenon called the "field effect." This relatively non-invasive and extremely accurate technique could mean great things for detecting colon cancer.
http://www.sciencedaily.com/releases/2009/06/090609122228.htm
Wednesday, March 30, 2011
So...who REALLY has ADHD?
Scientists have recently found genetic evidence for ADHD. Although characterized by differences in behavior and a lack of an adequate attention span, there is now evidence that children with ADHD are more likely to have DNA mutations than children without ADHD; in other words, they are more likely to have DNA duplications or missing DNA segments.
This finding is extremely significant in that it can provide a purely scientific backing to diagnoses of ADHD. In the case of a dispute or uncertainty, a test can be run that can compare the DNA of a possible ADHD child to one without ADHD. Interestingly, these differences in DNA are similar to the DNA mutations found in people with schizophrenia and autism.
A child's environment and raising is not yet being completely ignored as a possible contributor to the development of ADHD, but at least now genetics can be shown to play a part. This can help provide a much clearer, surer diagnosis.
Sources: http://www.sciencedaily.com/releases/2010/09/100929191312.htm
Synthetic Nano-Platelets Added to Blood Cut Healing Time in Half.
What happens when a person is in a bad accident is bleeding, and the paramedics arrive? They apply pressure to the wound to stop the bleeding. Currently researchers are developing synthetic nanoparticles to be injected into the site of injury that act as platelets, clotting and sealing off the wound. The platelets bond with one another as well as the naturally occurring platelets to seal off the wound. Scientist tested and observed that the quantity of time to form a clot in wounded rats was cut in half after the injection of the nanoparticles. Moreover, the artificial platelets even stop internal bleeding. If approved for use in people, this new invention could potentially double the amount of time emergency medical technicians have to move a patient from the site of the accident to nearest medical facility. Surgeons would have more time to locate and stop the bleeding sites on the patient’s body. Soldiers that receive wounds on the battlefield or even standard law enforcement could increase their survival rate if wounded in the line of duty.
I have family and friends that served and or are currently serving in the military. Finding a way to increase their chance of survival while fighting would mean a world to their families as well as me. My uncle is emergency room surgeon and this would also increase his patients’ likelihood of survival. If they could ever develop a version for personal use, there could be (possibly but likely several years away) a packet or dispenser of nanoparticles in every personal first aid kit. This would only be possible if they could produce the nanoparticles on a mass scale and cheaply.
Labels: http://www.popsci.com/science/article/2009-12/synthetic-nano-platelets-blood-cut-bleeding-time-half
MicroRNA in diabetic nephropathy
MicroRNAs are cellular RNA fragments that prevent the production of a particular protein by binding to and destroying the messenger RNA that would have produced the protein. These post translational modifiers have been found to contribute to the disease diabetic nephropathy (expansion of mesangial matrix that ultimately occludes glomerular capillaries) significantly, but their exact role in this renal disease is not well understood. This article describes the study of one such miRNA, miR-29c, which was identified by a comparative miRNA expression array to be prevalent in diabetic environments. The role of this particular miRNA was then studied by observing its expression in kidney cells in db/db mice (models of obesity, and diabetes), and by observing its effects in kidney microvascular endothelial cells and podocytes treated with high glucose in vitro. This microRNA was found to induce apoptosis of these cells (especially podocytes, which wrap around the capillaries of the glomerulus) and cause a buildup of extracellular matrix protein. To verify these results, the miRNA was inhibited, and the glucose induced cells did not apoptose. It was also found that when miR-29c was inhibited, there was reduced albuminuria (plasma protein in the urine) because the podocytes were not destroyed, and a reduction of kidney mesangial matrix accumulation in the db/db mice. These findings determined the large role that miR-29c plays in diabetic nephropathy, which is a major cause of mortality in patients with diabetes mellitus.
This article was very interesting because it specified the effects of a relatively newfound aspect in gene regulation (miDNA) in the pathology of diabetic nephropathy. This study could lead to developments in inhibiting the miRNA so that this condition is treated effectively, and so that mortality rates of patients with diabetes mellitus decrease. Diabetes mellitus patients could have longer life spans, because glomerular capillaries in the kidney would remain unobstructed.
http://www.jbc.org/content/early/2011/02/10/jbc.M110.194969.full.pdf
A New Found Voice
Vocal cord paralysis is a problem that can be brought on from disease or trauma, such as a stroke, that is more than just a hindrance to communication. Commonly, only one of the cords is paralyzed, but if both are, they expose the lung and increase the chance of debris entering past them, and also lead to breathing problems. Current methods of treatment involve electrical stimulation, surgery, and speech therapy. However, Leonessa recently won a grant from a proposal to insert an electrode-studded pad to the side of the throat that would utilize electric signals to the nerves that control vocal cords. The system design so far uses 32 pins that would be pushed just beneath the skin and hooked up to a device clipped onto a belt. Critics say that this is a far stretch though due to some vocal problems originating from brain damage, and the dangers of implanting this device near critical nerves for neck and head movement, as well as breathing and swallowing.
I found this article to be quite an interesting proposal since it's such a huge application of engineering to a medical problem. I'd be interested to see this device being made and capabilities as to how well people would sound and the range of tones and possibilities of people even singing again.
http://www.scientificamerican.com/article.cfm?id=vocal-cord-paralysis
Engineers Create New Detection Device For Cancer, HIV Cells
A new device which can detect single cancer cells within a blood sample was recently developed by a Harvard biomedical engineer and MIT aeronautical engineer. This advancement could lead to vast improvements in the detection of cancer metastasis as well as the detection of other diseases such as HIV. The microfluidic device is roughly the size of a dime and could be developed into low-cost tests which doctors could use for testing in countries without the financial resources for expensive diagnostic instruments.
The detection system consists of tens of thousands of porous, carbon nanotubes studded onto the device surface. Each nanotube post is coated with antibodies specific to cancer cells which cause these cells to stick to the post while allowing non-cancerous cells to pass through. Metastasis can be recognized by passing the patient's blood through the device. Ninety percent of deaths from cancer are not due to cancer at the original site, so detecting metastasis more easily could be a big step in fighting off this disease.
The device can be customized for other diseases in numerous ways. By selecting different antibodies, the device can target specific diseases such as HIV. The distance between nanotubes can also be increased or decreased, allowing bigger or smaller particles to pass through the device more easily. In this way, the device can be manipulated to trap particles which range from the size of tumor cells all the way down to viruses. This technology is therefore not just a leap for cancer research, but for medical research as a whole.
This article is interesting to me because I hope to work with and develop devices which utilize nanoscale technology. I think that the most promising future of medical devices lies in these technologies. Besides this detection device, numerous other nano-devices are being developed which may lead to longer lives, better disease control, and improved quality of life. I hope to be a part of this research as soon as possible.
Link: Catching cancer with carbon nanotubes
Blood Tests for Concussions
Concussions among athletes is a very popular subject in the news lately, (especially if watch Sports Center), a lot of research is being done on new helmets for football players as well as modifications to the rules to make penalties and fines for dangerous tackles more severe. It is a move in the right direction, but preventing concussions and traumatic brain injury is only half of the picture. Regardless of how advanced the equipment gets or how harsh fines for “leading with the helmet” become, concussions are still going to occur. The challenge then becomes how to diagnosis if a person has received a concussion and if so, how severe the damage is. As of now the method of concussion diagnosis is rather complicated and unclear. If a person is thought to have received some brain injury the most common ways to assess their trauma is to perform an neurological exam, which is often indistinct, or to have a more expensive look at the brain through radiological instruments like MRI’s or CT’s which are surprisingly not as helpful as one would think. This is why one U.S. Army doctor in Maryland is developing a method for detecting concussions through an easy blood test.
The theory behind this is just like that of the blood test for myocardial infractions. When a person has a heart attack the damaged heart cells leak out specific molecules, which then enter the blood where they can easily be detected by a blood test administered by a physician. Like the heart, when the brain is injured its cells leak out their own molecules into the blood. The idea is simple, but the research is quite complicated. Researchers are trying to decide which molecules are most likely to be signs of brain injury and what normal levels of those molecules are in the blood. This idea for a concussion blood test is a great example of a simple yet powerful solution to a medical problem. This is one of those things that will quickly be used by hospitals all over the world and make the path to treatment and recovery that much faster.
http://www.biomedicalblog.com/category/research/
"Nerve - Chip Hybrids"
One of the main goals many prosthetic researches strive for is the ability for humans to control prosthetic movement though neurons within the human brain. Although this might seem out of reach at the moment, researchers at the University of Wisconsin have started making strides to one day making this sci-fi inspired idea a reality. Researchers at the university have created an unproven version of a “nerve – chip hybrid”. Basically, tubes made out of silicon and germanium shows potential to be compatible with a neuron. Tests in lab mouse shows affinity for currents to pass though these semiconductors from brain nerve cells. In addition, when the tubes are made with the appropriate size, the tendrils of the nerves seem to be able to navigate though them with ease and formed complex structures. This demonstrates that these tubes have integrated perfectly with the nervous system. Although researchers are not completely sure whether the nerve cells can communicate with each other effectively using these tubes, this provides a starting step to a new age of controllable prosthetics.
Much of this article is speculation and testing, the research has not provided a definite answer about the new technology and ultimately this idea might not go much further in development. However, I still chose this article because of the potential to achieving something like this. Giving humans the ability to control prosthetics like a normal human body part would change the direction of bio-technology. The fact that this idea can even be deem possible and research have show that it can be achieved shows vast potential to finally gap the distance between reality and sci-fi.
Link: http://www.popsci.com/science/article/2011-03/silicon-chips-wired-nerve-cells-could-enable-new-brain-machine-interfaces
Angdi Liu - Section 502
Genetic pathways to starve cancer cells
This article is about gene therapy to starve specific types of kidney cancers. From this study a new class of drugs is being studied. They will inhibit cancer cells from generating the energy needed to survive. The new drugs will alter the gene expression in the cancerous cells and block the cells from using aerobic respiration. Approximately 1.5% of the United States population will be diagnosed with a form of kidney cancer. The drug will cause hypoxia-inducible factors to be initiated. These are factors that are normally found in cells during a period of hypoxia, thus starving the cancerous cells. Another possibility is 2-deoxy-D-glucose (2DG). 2DG is a glycolic inhibitor that in lab tests inhibited glycolysis and killed the tumor cells. The gene therapy treatment presented in this article would provide a noninvasive treatment with minimal side effects. This is a much better alternative to the current treatment of chemo-radiation.
I choose this article because it is addressing a hot topic of health, cancer. It is presents a unique and possible solution to specific forms of cancer. This new treatment could improve/save the lives of approximately 1.5% of the US population.
http://www.sciencedaily.com/releases/2011/03/110330111355.htm
Research Into Poison Curare May Lead to Medication Against Tobacco Addiction
I found this article interesting not only because millions of people around the world are struggling with tobacco addiction, but also because the prolonged usage of tobacco based drugs lead to all sorts of health issues. With development of a drug to aid in addiction relief, many of those addicted may be able to gradually return to a relatively healthy physical state.
Source: http://www.sciencedaily.com/releases/2011/03/110330101040.htm
Progression Towards Cracking Long QT Syndrome
This article was very significant to me since it tied into the lecture that we had over Cardiovascular Physiology. It also impacted me since Long QT syndrome seemed like a mysterious one; a syndrome that someone could just mysteriously be affected by on a random day.
http://news.sciencemag.org/sciencenow/2011/03/heart-defect-medicate-or-wait.html?ref=hp
Nanodrug Fights Breast Cancer From Inside Without Harming Healthy Tissue
Cell-Phone-Based Platform for Biomedical Device Development and Education Applications
In this paper we report the development of two attachments to a commercial cell phone that transform the phone's integrated lens and image sensor into a 350× microscope and visible-light spectrometer. The microscope is capable of transmission and polarized microscopy modes and is shown to have 1.5 micron resolution and a usable field-of-view of 150×150 with no image processing, and approximately 350×350 when post-processing is applied. The spectrometer has a 300 nm bandwidth with a limiting spectral resolution of close to 5 nm. We show applications of the devices to medically relevant problems. In the case of the microscope, we image both stained and unstained blood-smears showing the ability to acquire images of similar quality to commercial microscope platforms, thus allowing diagnosis of clinical pathologies. With the spectrometer we demonstrate acquisition of a white-light transmission spectrum through diffuse tissue as well as the acquisition of a fluorescence spectrum. We also envision the devices to have immediate relevance in the educational field.
I found this article interesting because of the integration of education in a user interface that allowed useres to interact with a system increasing knowledge.
Painless Laser Tissue Analysis Could Replace X-Rays Within Five Years
A new way to detect cancer and HIV
Women Who Drink Beer More Likely to Develop Psoriasis
Brigham and Women's Hospital/Harvard Medical School scientists have found a curious correlation between drinking regular beer and developing the common autoimmune skin disease, psoriasis. This association between alcohol consumption and an increased risk for psoriasis, or worsening of it, has been suspected, and these researchers decided to investigate the relationship further. In their study, in 1991 82,869 women of age 27 to 44 were questioned about their alcohol consumption and if they had the disease. By 2005, 1,150 cases had developed in the women. From these cases, the risk of psoriasis was shown to be 72% greater in women who drank 2.3 drinks per week or more than women who did not drink at all. Also, women who drank non-light beer specifically revealed a risk 1.8 times greater. Other forms of alcohol, including light beer, curiously showed no relevance to risk. This suggested that a certain component found in only in regular beer could increase the risk of psoriasis. The researchers hypothesized this component as potentially the starch source in beer, perhaps barley. Barley and other grains could irritate the psoriasis in patients and would not be found in other alcoholic beverages and would be found in lower amounts in light beer, explaining this unexpected connection.
This article caught my eye for many reasons. For one, I actually have a very very mild case of psoriasis (unrelated to drinking regular beer). Although it is so mild that it can hardly be considered psoriasis, I still find articles and information about the disease interesting. Also, I found this correlation (and how specific it was) between regular beer and psoriasis very random and bizarre. I think it’s intriguing that two completely unrelated things can actually be proven related with some investigation. Perhaps there are many unlikely things causing or contributing to our most deleterious diseases.
Music is all in the mind: A brain–computer interface allows paralysed patients to play music with brainpower alone.
The development of this brain-computer interface could work wonders for improving patient morale and putting a feeling of control back into the life of a patient who has become paralyzed for one reason or another. This brain-computer interface allows a patient to play music simply by thinking about it. The interface uses EEG (electroencephalography) to pick up the faint neural signals from a patient focusing on a selection of notes displayed on a screen. The focus on a particular note creates a distinctive and detectable pattern in the EEG signal, which then triggers the corresponding musical event. The patient directs their attention at one of the musical notes displayed on the screen, and the intensity, or loudness, of the musical note can be altered by the intensity of attention focused on that particular note. Since the system relies on eye movement for the patient to be able to focus and devote their attention to a particular note, this interface requires that patients be able to control their eye movements. Not only is this new interface innovative, but it could beginning of a new wave of technologies to be developed to assist those who have difficulty performing basic tasks on their own.
This article was very interesting for me because of the implications it has for possible future technology. Maybe I can someday do my laundry by simply thinking about it.
Article:
http://www.nature.com/news/2011/110318/full/news.2011.113.html
Tastes Like Asthma Medicine
Tuesday, March 29, 2011
First commercial 3-D bio-printer makes human tissue and organs
Gene therapy for Parkinson's
Andrew Feingin of the Feinstein Institute for Medical Research conducted an "open lab" trial in 2007 that injected glutamic acid decarboxylase (GAD), a gene the promotes the production of GABA, helps improve the condition of Parkinson's patients.
To put this therapy to the test, another trial was conducted. This time it was a double blind trial where only the surgeons, not the patients or the doctors, know who received the placebo or who received the treatment. During this trial, 65 people with Parkinson's were used a subjects - 23 received the treatment, 22 received a saline solution, and 20 received nothing. At one, three, and six months later, the researchers took measurements of the patients symptoms and found that those who had received the treatment showed a 23.1 percent improvement in motor functions. The patients who had received the saline solution showed only a 12.7 percent improvement. Overall, the treatment was affective and well tolerated.
I found this article interesting because I know that advancements in Parkinson's have been sparse. This treatment shows incredible strides in the improvements in the motor skills of these patients and provides a promising future for Parkinson's research.
Implantable device for sleep apnea
Treadmill Tests for Poison Frogs Show Toxic Species Are More Physically Fit
Thought-Controlled Prosthetic Limb System to Be Tested on Human Subjects
Many research groups have been looking into the brain activity involved in the different motions of the arm. They have used microarrays to record and stimulate the brain. They want this information so that they could use implantable neural interfaces to control the arm. Researchers are also trying to figure out some of the signals that provide the sensory feedback. If they could get all this patients would have a prosthetic that weighed close to a normal arm, would allow feeling, controlled by thought, and many degrees of movement. This would be a tremendous breakthrough in the field of orthopedics, and would make a big difference in many people's lives.
I was interested in this article, because the field of prosthesis is very interesting to me. It is also amazing to see how far science is going to understanding how everything works in the human body. The url for the article is http://www.sciencedaily.com/releases/2010/08/100804081227.htm.
New Cancer Drug Heads to Clinical Trials
Programmed cell death, commonly referred to as apoptosis, is a normal and highly regulated process where cells die after a set time period. This process is used to remove defective and unnecessary cells. Deregulation of apoptosis and an irregular system are usually signs of cancer. When cancer forms in the body, the cancer cells do not have an apoptotic course, so they grow uncontrollably and indefinitely. Current cancer treatments, such as chemotherapy, immunotherapy and radiation work by inducing apoptosis in the cancer cells. This is not always effective though because of the irregular apoptotic pathways in the cancer cells, and they often become resistant to these therapies. Dr. Shaomeng Wang and his team have created a new drug that seems to be solving this issue. AT-406 works by removing the proteins that block apoptosis in cancer cells, therefore promoting apoptosis of the cancer cells, and directly reducing the resistance to other treatments of these cells. These proteins are called IAP’s, or inhibitor of apoptosis proteins. In the clinical trials of AT-406, the drug has had minimal, if any, effect on normal cells, and it reduced tumor size and caused few side effects.
I chose this article because it deals with cancer research, and I am very interested in both the research aspect and also pharmacology. I found it fascinating how the doctors are tweaking current therapies, and creating a whole new class of drugs that seem to be working remarkably well in the battle against cancer.
Article: http://www.sciencedaily.com/releases/2011/03/110329134302.htm
Picture: http://www.ascenta.com/development/index.php